The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Open accessAbstract
The lack of in vitro prostate cancer models that recapitulate the diversity of human prostate cancer has hampered progress in understanding disease pathogenesis and therapy response. Using a 3D organoid system, we report success in long-term culture of prostate cancer from biopsy specimens and circulating tumor cells. The first seven fully characterized organoid lines recapitulate the molecular diversity of prostate cancer subtypes, including TMPRSS2-ERG fusion, SPOP mutation, SPINK1 overexpression, and CHD1 loss. Whole-exome sequencing shows a low mutational burden, consistent with genomics studies, but with mutations in FOXA1 and PIK3R1, as well as in DNA repair and chromatin modifier pathways that have been reported in advanced disease. Loss of p53 and RB tumor suppressor pathway function are the most common feature shared across the organoid lines. The methodology described here should enable the generation of a large repertoire of patient-derived prostate cancer lines amenable to genetic and pharmacologic studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumor tissue, derived from either biopsies or surgical resections, is also typically processed akin to normal tissue to isolate tumour cells to grow as organoids16,49–51.”
From Organoids (2022) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Self-citationIncreased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Scher, H. I., Fizazi, K., Saad, F., Taplin, M.-E., Sternberg, C. N., Miller, K., de Wit, R., Mulders, P., Chi, K. N., Shore, N. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207506 · Cited by 4,586
Self-citationAbiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407 · cited 1×
“These include the next-generation antiandrogen enzalutamide and the androgen synthesis inhibitor abiraterone acetate, both of which have been shown to significantly prolong life (de Bono et al., 2011; Ryan et al., 2012; Scher et al., 2012).”
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,000
Cancer research using organoid technology
Kretzschmar, K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01990-z · Cited by 120
Organoids are not organs: Sources of variation and misinformation in organoid biology
Jensen, K. B., & Little, M. H. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.009 · Cited by 127
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and TherapiesPreprint
Puca, L., Vlachostergios, P. J., & Beltran, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030593 · Cited by 120
Self-citationYang, Z., Xu, H., & Zhao, X. (2020) · Advanced Science · doi:10.1002/advs.201903718 · Cited by 124
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma
Lampis, A., Carotenuto, P., Vlachogiannis, G., Cascione, L., Hedayat, S., Burke, R., Clarke, P. A., Bosma, E., Simbolo, M., Scarpa, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.10.043 · Cited by 116
Revisiting the role of Wnt/β-catenin signaling in prostate cancer
Schneider, J. A., & Logan, S. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.008 · Cited by 115
Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases
Francart, M., Lambert, J., Vanwynsberghe, A. M., Thompson, E. W., Bourcy, M., Polette, M., & Gilles, C. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24506 · Cited by 118
EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
Genna, A., Vanwynsberghe, A. M., Villard, A. V., Pottier, C., Ancel, J., Polette, M., & Gilles, C. (2020) · Cancers · doi:10.3390/cancers12061632 · Cited by 118
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
Bolis, M., Bossi, D., Vallerga, A., Ceserani, V., Cavalli, M., Impellizzieri, D., Rito, L. D., Zoni, E., Mosole, S., Elia, A. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26840-5 · Cited by 124
Self-citationFunctional precision oncology using patient-derived assays: bridging genotype and phenotype
van Renterghem, A. W. J., van de Haar, J., & Voest, E. E. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00745-2 · Cited by 121
Rybak, A. P., Bristow, R. G., & Kapoor, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2953 · Cited by 122
3D and organoid culture in research: physiology, hereditary genetic diseases and cancer
Suarez-Martinez, E., Suazo-Sanchez, I., Celis-Romero, M., & Carnero, A. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00775-w · Cited by 118
Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression
Chakraborty, G., Armenia, J., Mazzu, Y. Z., Nandakumar, S., Stopsack, K. H., Atiq, M. O., Komura, K., Jehane, L. E., Hirani, R., Chadalavada, K., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1570 · Cited by 116
Self-citationYu, L., Li, Z., Mei, H., Li, W., Chen, D., Liu, L., Zhang, Z., Sun, Y., Song, F., Chen, W., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1248 · Cited by 113
Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
Li, Z., Xu, H., Yu, L., Wang, J., Meng, Q., Mei, H., Cai, Z., Chen, W., & Huang, W. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.970 · Cited by 120
Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy
Maheswaran, S., & Haber, D. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0145 · Cited by 110
Fong, E. L. S., Wan, X., Yang, J., Morgado, M., Mikos, A. G., Harrington, D. A., Navone, N. M., & Farach‐Carson, M. C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.059 · Cited by 111
Wang, S., Wang, Y., Xun, X., Zhang, C., Xiao, X., Cheng, Q., Hu, S., Li, Z., & Zhu, J. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-1523-2 · Cited by 112
Ethical issues in human organoid and gastruloid research
Munsie, M., Hyun, I., & Sugarman, J. (2017) · Development · doi:10.1242/dev.140111 · Cited by 111
Li, W., Zhou, Z., Zhou, X., Khoo, B. L., Gunawan, R., Chin, Y. R., Zhang, L., Yi, C., Guan, X., & Yang, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202609 · Cited by 119
Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
Rebello, R. J., Pearson, R. B., Hannan, R. D., & Furic, L. (2017) · Genes · doi:10.3390/genes8020071 · Cited by 110
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
Kapeleris, J., Kulasinghe, A., Warkiani, M. E., Vela, I., Kenny, L., O'Byrne, K. J., & Punyadeera, C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00311 · Cited by 111
Self-citationSeidlitz, T., Koo, B., & Stange, D. E. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00662-2 · Cited by 112
Organoids as a model system for studying human lung development and disease
Nadkarni, R. R., Abed, S., & Draper, J. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.091 · Cited by 106
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis
Lambros, M. B. K., Seed, G., Sumanasuriya, S., Gil, V., Crespo, M., Fontes, M. S., Chandler, R., Mehra, N., Fowler, G., Ebbs, B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0862 · Cited by 108
Cancer organoid co-culture model system: Novel approach to guide precision medicine
Yuan, J., Li, X., & Yu, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1061388 · Cited by 114
Stem Cells: A Renaissance in Human Biology Research
Wu, J., & Belmonte, J. C. I. (2016) · Cell · doi:10.1016/j.cell.2016.05.043 · Cited by 111
Xiang, D., He, A., Zhou, R., Wang, Y., Xiao, X., Gong, T., Kang, W., Lin, X., Wang, X., Consortium11, P.-B. D., et al. (2024) · Theranostics · doi:10.7150/thno.96027 · Cited by 108
Self-citationPreclinical models of pancreatic ductal adenocarcinoma
Hwang, C., Boj, S. F., Clevers, H. C., & Tuveson, D. A. (2015) · The Journal of Pathology · doi:10.1002/path.4651 · Cited by 105
Self-citationNg, S., Tan, W. J., Pek, M. M. X., Tan, M.-H., & Kurisawa, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119400 · Cited by 105
A pan-cancer organoid platform for precision medicine
Larsen, B. M., Kannan, M., Langer, L. F., Leibowitz, B. D., Bentaieb, A., Cancino, A., Dolgalev, I., Drummond, B. E., Dry, J. R., Ho, C.-S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109429 · Cited by 105
Moreira, L., Bakir, B. S., Chatterji, P., Dantes, Z., Reichert, M., & Rustgi, A. K. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.004 · Cited by 112
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
Klein, E., Hau, A., Oudin, A., Golebiewska, A., & Niclou, S. P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.604121 · Cited by 102
Engineered Microsystems for Spheroid and Organoid Studies
Kang, S., Kim, D., Lee, J., Takayama, S., & Park, J. Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001284 · Cited by 100
Organoids: a novel modality in disease modeling
Heydari, Z., Moeinvaziri, F., Agarwal, T., Pooyan, P., Shpichka, A. I., Maiti, T. K., Timashev, P. S., Baharvand, H., & Vosough, M. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00150-7 · Cited by 106
Zhou, C., Li, C., Luo, L., Li, X., Jia, K., He, N., Mao, S., Wang, W., Shao, C., Liu, X., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.06.001 · Cited by 102
Self-citationThe Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
Azar, J. H., Bahmad, H. F., Daher, D., Moubarak, M. M., Hadadeh, O., Monzer, A., Bitar, S. A., Jamal, M., Al‐Sayegh, M., & Abou-Kheir, W. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147667 · Cited by 106
Ding, R., Chen, P., Rajendran, B. K., Lyu, X., Wang, H., Bao, J., Zeng, J., Hao, W., Sun, H., Wong, A. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23379-3 · Cited by 97
Functional Studies on Viable Circulating Tumor Cells
Pantel, K., & Alix‐Panabières, C. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.242537 · Cited by 96
Patient-derived organoids: a promising model for personalized cancer treatment
Yang, H., Sun, L., Liu, M., & Mao, Y. (2018) · Gastroenterology report · doi:10.1093/gastro/goy040 · Cited by 97
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
Düzağaç, F., Saorin, G., Memeo, L., Canzonieri, V., & Rizzolio, F. (2021) · Cancers · doi:10.3390/cancers13040737 · Cited by 97
Heinzelmann, E., Piraino, F., Costa, M., Roch, A., Norkin, M. N., Garnier, V., Homicskó, K., & Brandenberg, N. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100197 · Cited by 109
Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024) · MedComm · doi:10.1002/mco2.735 · Cited by 100
Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells
Kudelka, M. R., Antonopoulos, A., Wang, Y., Duong, D. M., Song, X., Seyfried, N. T., Dell, A., Haslam, S. M., Cummings, R. D., & Ju, T. (2015) · Nature Methods · doi:10.1038/nmeth.3675 · Cited by 95
Foglietta, F., Canaparo, R., Muccioli, G., Terreno, E., & Serpe, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117784 · Cited by 101
Kim, S. K., Kim, Y. H., Park, S., & Cho, S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.002 · Cited by 96
Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field
Williams, J. A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030041 · Cited by 97
Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer
Ding, Y., Li, N., Dong, B., Guo, W., Wei, H., Chen, Q., Yuan, H., Han, Y., Chang, H., Kan, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123557 · Cited by 93
Self-citationKarakasheva, T. A., Kijima, T., Shimonosono, M., Maekawa, H., Sahu, V., Gabre, J. T., Cruz‐Acuña, R., Giroux, V., Sangwan, V., Whelan, K. A., et al. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.109 · Cited by 92
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Foo, M. A., You, M., Chan, S. L., Sethi, G., Bonney, G. K., Yong, W. P., Chow, E. K., Fong, E. L. S., Wang, L., & Goh, B.-C. (2022) · Biomarker Research · doi:10.1186/s40364-022-00356-6 · Cited by 100
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 103
Soler, A., Cayrefourcq, L., Mazard, T., Babayan, A., Lamy, P., Assou, S., Assénat, E., Pantel, K., & Alix‐Panabières, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34365-z · Cited by 92
Engineering Precision Medicine
Sun, W., Lee, J., Zhang, S., Benyshek, C., Dokmeci, M. R., & Khademhosseini, A. (2018) · Advanced Science · doi:10.1002/advs.201801039 · Cited by 96
The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
Yan, Y., Ma, J., Wang, D., Lin, D., Pang, X., Wang, S., Zhao, Y., Shi, L., Xue, H., Pan, Y., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910659 · Cited by 92
Self-citationLi, F., Han, M., Dai, P., Xu, W., He, J., Tao, X., Wu, Y., Tong, X., Xia, X., Guo, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21171-x · Cited by 98
Self-citationTissue-engineered models of human tumors for cancer research
Villasante, A., & Vunjak‐Novakovic, G. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1009442 · Cited by 96
Cellular plasticity: 1712 to the present day
Tata, P. R., & Rajagopal, J. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.07.005 · Cited by 93
Three-dimensional cell culture: from evolution to revolution
Alhaque, S., Themis, M., & Rashidi, H. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0216 · Cited by 92
Development and application of human adult stem or progenitor cell organoids
Rookmaaker, M. B., Schutgens, F., Verhaar, M. C., & Clevers, H. C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.118 · Cited by 91
Self-citationERF mutations reveal a balance of ETS factors controlling prostate oncogenesis
The International SU2C/PCF Prostate Cancer Dream Team, Bose, R., Karthaus, W. R., Armenia, J., Abida, W. M., Iaquinta, P. J., Zhang, Z., Wongvipat, J., Wasmuth, E. V., Shah, N., et al. (2017) · Nature · doi:10.1038/nature22820 · Cited by 90
Self-citationBarros-Silva, J. D., Linn, D. E., Steiner, I., Guo, G., Ali, A., Pakula, H., Ashton, G., Peset, I., Brown, M. D., Clarke, N. W., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.069 · Cited by 89
Bioprinting of in vitro tumor models for personalized cancer treatment: a review
Mao, S., Pang, Y., Liu, T., Shao, Y., He, J., Yang, H., Mao, Y., & Sun, W. (2020) · Biofabrication · doi:10.1088/1758-5090/ab97c0 · Cited by 90
Tosca, E. M., Ronchi, D., Facciolo, D., & Magni, P. (2023) · Biomedicines · doi:10.3390/biomedicines11041058 · Cited by 95
Cell spheroid creation by transcytotic intercellular gelation
Guo, J., Wang, F., Huang, Y., He, H., Tan, W., Yi, M., Egelman, E. H., & Xu, B. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01401-7 · Cited by 90
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications
Dai, C. S., Mishra, A., Edd, J., Toner, M., Maheswaran, S., & Haber, D. A. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.07.008 · Cited by 104
Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic Approaches
Hu, X., & Zhang, Z. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.11.003 · Cited by 94
Circulating tumor cells and CDX models as a tool for preclinical drug development
Lallo, A., Schenk, M. W., Frese, K. K., Blackhall, F. H., & Dive, C. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.08.01 · Cited by 94
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
Carceles‐Cordon, M., Kelly, W. K., Gomella, L. G., Knudsen, K. E., Rodríguez-Bravo, V., & Domenech, J. M. D. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0298-8 · Cited by 97
Saeed, K., Rahkama, V., Eldfors, S., Bychkov, D., Mpindi, J. P., Yadav, B., Paavolainen, L., Aittokallio, T. A., Heckman, C. A., Wennerberg, K., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.04.019 · Cited by 89
Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
Kulasinghe, A., Tran, T., Blick, T., O'Byrne, K. J., Thompson, E. W., Warkiani, M. E., Nelson, C. C., Kenny, L., & Punyadeera, C. (2017) · Scientific Reports · doi:10.1038/srep42517 · Cited by 88
Opportunities for organoids as new models of aging
Hu, J. L., Todhunter, M. E., LaBarge, M. A., & Gartner, Z. J. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201709054 · Cited by 92
Illuminating the noncoding genome in cancer
Zhang, X., & Meyerson, M. M. (2020) · Nature Cancer · doi:10.1038/s43018-020-00114-3 · Cited by 86
Papaccio, F., García-Micó, B., Gimeno-Valiente, F., Cabeza-Segura, M., Gambardella, V., Gutiérrez-Bravo, M. F., Alfaro‐Cervelló, C., Martínez‐Ciarpaglini, C., Rentero-Garrido, P., Zúñiga, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02591-z · Cited by 91
The potential of organoids in urological cancer research
Wang, S., Gao, D., & Chen, Y. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.65 · Cited by 87
Self-citationCurrent Status of Patient-Derived Ovarian Cancer Models
Maru, Y., & Hippo, Y. (2019) · Cells · doi:10.3390/cells8050505 · Cited by 92
De Angelis, M. L., Francescangeli, F., Nicolazzo, C., Signore, M., Giuliani, A., Colace, L., Boe, A., Magri, V., Baiocchi, M., Ciardi, A., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02263-y · Cited by 75
Organoids: An intermediate modeling platform in precision oncology
Jin, M., Han, R.-R., Qiu, G., Ju, X.-C., Lou, G., & Jin, W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.021 · Cited by 90
Hepburn, A. C., Steele, R. E., Veeratterapillay, R., Wilson, L., Kounatidou, E. E., Barnard, A., Berry, P., Cassidy, J., Moad, M., El‐Sherif, A., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0712-y · Cited by 89
Wang, Q., Yuan, F., Zuo, X., & Li, M. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02505-w · Cited by 101
Shukla, S., Cyrta, J., Murphy, D. A., Walczak, E. G., Ran, L., Agrawal, P. K., Xie, Y., Chen, Y., Wang, S., Zhan, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.008 · Cited by 83
Self-citationProstate Luminal Progenitor Cells in Development and Cancer
Zhang, D., Zhao, S., Li, X., Kirk, J. S., & Tang, D. G. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.09.003 · Cited by 92
Zhu, J., Ji, L., Chen, Y., Li, H., Huang, M., Dai, Z., Wang, J., Xiang, D., Fu, G., Lei, Z., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01354-9 · Cited by 92
Self-citationOrganoids as Models for Neoplastic Transformation
Neal, J. T., & Kuo, C. J. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044249 · Cited by 85
Halstead, A. M., Kapadia, C. D., Bolzenius, J. K., Chu, C. E., Schriefer, A. E., Wartman, L. D., Bowman, G. R., & Arora, V. K. (2017) · eLife · doi:10.7554/elife.30862 · Cited by 87
Self-citationGenerating human prostate cancer organoids from leukapheresis enriched circulating tumour cells
Mout, L., van Dessel, L. F., Kraan, J., de Jong, A. C., Neves, R. P., Erkens‐Schulze, S., Beaufort, C. M., Sieuwerts, A. M., van Riet, J., Woo, T. L. C., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.03.023 · Cited by 87
Servant, R., Garioni, M., Vlajnic, T., Blind, M., Pueschel, H., Müller, D. C., Zellweger, T., Templeton, A. J., Garofoli, A., Maletti, S., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5698 · Cited by 82
Self-citationThree-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma
Takai, A., Fako, V. E., Dang, H. T., Forgues, M., Yu, Z., Budhu, A., & Wang, X. W. (2016) · Scientific Reports · doi:10.1038/srep21174 · Cited by 85
Integrated cancer tissue engineering models for precision medicine
Bregenzer, M. E., Horst, E. N., Mehta, P., Novak, C. M., Raghavan, S. A., Snyder, C. S., & Mehta, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216564 · Cited by 84
Lim, J., Ching, H., Yoon, J., Jeon, N. L., & Kim, Y. (2021) · Nano Convergence · doi:10.1186/s40580-021-00261-y · Cited by 85
Cardiac organoid — a promising perspective of preclinical model
Zhao, D., Lei, W., & Hu, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02340-7 · Cited by 84
Role of Patient-Derived Models of Cancer in Translational Oncology
Idrisova, K., Simon, H., & Gomzikova, M. O. (2022) · Cancers · doi:10.3390/cancers15010139 · Cited by 84
Drug Sensitivity Assays of Human Cancer Organoid Cultures
Francies, H. E., Barthorpe, A. S., McLaren-Douglas, A., Barendt, W. J., & Garnett, M. J. (2016) · Methods in molecular biology · doi:10.1007/7651_2016_10 · Cited by 82
Rodenhizer, D., Dean, T., D'Arcangelo, E., & McGuigan, A. P. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701174 · Cited by 80
Laget, S., Broncy, L., Hormigos, K., Dhingra, D. M., BenMohamed, F., Capiod, T., Østerås, M., Farinelli, L., Jackson, S. M., & Paterlini-Bréchot, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169427 · Cited by 81
Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
Yang, Y. A., & Yu, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.01.003 · Cited by 84
Mills, A. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026450 · Cited by 83
Cortés‐Hernández, L. E., Eslami‐S, Z., & Alix‐Panabières, C. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.008 · Cited by 84
Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model
Kwon, O.-J., Zhang, L., Wang, J., Su, Q., Feng, Q. F., Zhang, X. H.-F., Mani, S. A., Paulter, R., Creighton, C. J., Ittmann, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84637 · Cited by 77
Faugeroux, V., Pailler, E., Oulhen, M., Déas, O., Brullé, L., Hervieu, C., Marty, V., Alexandrova, K., Andree, K., Stoecklein, N. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15426-2 · Cited by 87
Palanisamy, N., Yang, J., Shepherd, P. D. A., Li-Ning-Tapia, E. M., Labanca, E., Manyam, G. C., Ravoori, M. K., Kundra, V., Araujo, J. C., Efstathiou, E., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0479 · Cited by 78
Metadata
- Authors
- Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., Wongvipat, J., Kossai, M., Ramazanoglu, S., Barboza, L. P., Di, W., Cao, Z., Zhang, Q. F., Sirota, I., Ran, L., MacDonald, T. Y., Beltran, H., Mosquera, J.-M., Touijer, K. A., Scardino, P. T., Laudone, V. P., Curtis, K. R., Rathkopf, D. E., Morris, M. J., Danila, D. C., Slovin, S. F., Solomon, S. B., Eastham, J. A., Chi, P., Carver, B., Rubin, M. A., Scher, H. I., Clevers, H., Sawyers, C. L., & Chen, Y.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- NewYork–Presbyterian Hospital (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- Corresponding author
- Sawyers, Charles L.
- Chen, Yu
- ORCID
- Gao, Dong
- Vela, Ian
- Sboner, Andrea
- Karthaus, Wouter R.
- Gopalan, Anuradha
- Dowling, Catherine
- Arora, Vivek K.
- Di, Wei
- Cao, Zhen
- Sirota, Inna
- Ran, Leili
- Beltran, Himisha
- Scardino, Peter T.
- Laudone, Vincent P.
- Rathkopf, Dana E.
- Morris, Michael J.
- Danila, Daniel C.
- Slovin, Susan F.
- Solomon, Stephen B.
- Chi, Ping
- Carver, Brett
- Rubin, Mark A.
- Scher, Howard I.
- Clevers, Hans
- Sawyers, Charles L.
- Chen, Yu
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 159
- Issue
- 1
- Pages
- 176-187
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4237931
- OpenAlex
- W2059586354
- Cited by
- 1,559
- References
- 50
- Citations by year
- 2026: 110 · 2025: 117 · 2024: 138 · 2023: 145 · 2022: 155 · 2021: 172 · 2020: 180 · 2019: 131 · 2018: 131 · 2017: 120 · 2016: 87 · 2015: 67 · 2014: 5
- FWCI
- 73.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion)
- NSUWorks (Nova Southeastern University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Funders
- U.S. Department of Defense (W81XWH, W81XWH1010197)
- American Association for Cancer Research (SU2C-AACR-DT0712)
- Prostate Cancer Foundation (SU2C-AACR-DT0712)
- Memorial Sloan-Kettering Cancer Center (P50CA092629)
- Movember Foundation
- National Institutes of Health (W81XWH, UL1TR000457)
- Stand Up To Cancer (SU2C-AACR-DT0712)
- National Cancer Institute (R01CA182503, K08CA151660, R01CA116337, CA155169-01A1, K08CA140946, R01CA155169, P30CA008748, P50CA092629, R01CA193837)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- prostate cancer, organoids, circulating tumor cells, 3D organoid culture, TMPRSS2-ERG fusion, SPOP mutations, FOXA1, PIK3R1, DNA repair mutations, p53 deficiency, mutational burden, advanced prostate cancer
- MeSH terms
- Humans, Male, Neoplasm Metastasis, Organoids, Pharmacology, Prostatic Neoplasms, Tumor Suppressor Proteins, Culture Techniques, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
